subject area of
- A Selective Inhibitor and Probe of the Cellular Functions of Jumonji C Domain-Containing Histone Demethylases Journal Article
- A redox pathway leading to the alkylation of nucleic acids by doxorubicin and related anthracyclines: Application to the design of antitumor drugs for resistant cancer Journal Article
- Alchemical free energy methods for drug discovery: progress and challenges Journal Article
- Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactions Journal Article
- Applications of S-layers Journal Article
- Best Practices in Free Energy Calculations for Drug Design Journal Article
- Cell biology - Lessons in rational drug design for protein kinases Journal Article
- Chemical genetics and drug screening in Drosophila cancer models Journal Article
- Chemically Precise Glycoengineering Improves Human Insulin Journal Article
- Computationally Designed Peptide Inhibitors of the Ubiquitin E3 Ligase SCFFbx4 Journal Article
- Controlled release from crosslinked degradable networks Journal Article
- Design, synthesis, and biological evaluation of doxorubicin - Formaldehyde conjugates targeted to breast cancer cells Journal Article
- Design, synthesis, and preliminary evaluation of doxazolidine carbamates as prodrugs activated by carboxylesterases Journal Article
- Direct calculation of the binding free energies of FKBP ligands Journal Article
- Doxorubicin-formaldehyde conjugates targeting αvβ3 integrin Journal Article
- Drug discovery - Keeping pace with genomics through combinatorial chemistry Journal Article
- Dynamic Microenvironments: The Fourth Dimension Journal Article
- Future directions in the treatment of oral cancer Journal Article
- Glia: A novel drug discovery target for clinical pain Journal Article
- Gold-Catalyzed Cyclization Leads to a Bridged Tetracyclic Indolenine that Represses beta-Lactam Resistance Journal Article
- Guidelines for the analysis of free energy calculations Journal Article
- HIGH-AFFINITY SSDNA INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS Journal Article
- Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-RafV600E kinase Journal Article
- LETS GET SPECIFIC - THE RELATIONSHIP BETWEEN SPECIFICITY AND AFFINITY Journal Article
- Memory Unlocks the Future of Biomolecular Dynamics: Transformative Tools to Uncover Physical Insights Accurately and Efficiently Journal Article
- Microbially Guided Discovery and Biosynthesis of Biologically Active Natural Products Journal Article
- New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention Journal Article
- Overview of the SAMPL5 host-guest challenge: Are we doing better? Journal Article
- PEG Hydrogels for the Controlled Release of Biomolecules in Regenerative Medicine Journal Article
- Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety Journal Article
- Potent and selective pyrazole-based inhibitors of B-Raf kinase Journal Article
- Proteornics and genomics: Perspectives on drug and target discovery Journal Article
- Quinazolin-2-ylamino-quinazolin-4-ols as novel non-nucleoside inhibitors of bacterial DNA polymerase III Journal Article
- RNA PSEUDOKNOTS THAT INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE Journal Article
- Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers. Journal Article
- Rational design and synthesis of androgen receptor-targeted nonsteroidal anti-androgen ligands for the tumor-specific delivery of a doxorubicin-formaldehyde conjugate Journal Article
- Structure-Activity Relationship of Flavin Analogues That Target the Flavin Mononucleotide Riboswitch Journal Article
- The SELEX process: a surprising source of therapeutic and diagnostic compounds. Journal Article
- Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant Journal Article